What iSelect Fund does

iSelect Fund is a privately held, evergreen venture capital firm founded in 2014 and headquartered in St. Louis, Missouri, with team members in New York, Boston, and San Francisco. The firm invests at the intersection of food, agriculture, soil health, and human health — anchored by a 'Food is Health' thesis that frames poor nutrition as a driver of chronic disease and rising healthcare costs. iSelect targets early-stage companies in agriculture technology, cardiometabolic healthcare, and resource efficiency, and has built a portfolio of roughly 50-70+ companies representing 2,500+ combined employees.

iSelect's core offering is not a software product but a curated investment platform: accredited investors, family offices, wealth managers, and institutional clients gain access to vetted early-stage opportunities alongside tier-one venture co-investors such as Google Ventures, Andreessen Horowitz, Menlo Ventures, Y Combinator, S2G Investments, and Anterra Capital. Each investment is supported by up to 120 hours of due diligence drawn from a network of 200+ industry advisors with over 3,000 years of combined experience, including 30 PhDs, 40 startup founders, and 20 prior exits. Securities are distributed through North Capital Private Securities (Member FINRA/SIPC), which provides the regulatory and broker-dealer infrastructure for the offering.

iSelect generates returns through venture fund management — managing evergreen capital, participating in follow-on rounds via participation rights, and earning economics from successful exits. The firm has no publicly disclosed revenue, AUM, or fee schedule. It pursues thought-leadership distribution through the Crusonia Conversations podcast, the AgriFood Conversations webinar series, and CEO Carter Williams' public policy work, including 2024 U.S. Senate testimony on 'Feeding a Healthier America.' Recent strategic moves include follow-on participation in Miraterra's $16M CAD seed extension (March 2026) and an investment collaboration with The Nature Conservancy focused on soil health.

Name

iSelect Fund

Legal name

iSelect Fund

Website

https://iselectfund.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

iSelect Fund is a privately held evergreen venture capital firm that invests at the intersection of food, agriculture, soil health, and human health, offering accredited investors, family offices, wealth managers, and institutions vetted early-stage deals alongside tier-one VC co-investors.

Ownership category

akta.pro rank

Product category

Venture Capital and Impact Investing

NAICS

Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282), Security & Commodity Brokers, Dealers, Exchanges & Services (6200)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industries

Portfolio Construction & Asset Allocation Advisory (FSAEAAAC), Due Diligence Advisory (Commercial/Financial/Operational) (BPAHADAE)

Keywords

• Venture capital fund
• Early-stage investing
• Agtech investment
• Food health thesis
• Impact venture investing

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Venture Fund Management: iSelect generates returns by investing in early-stage companies in agriculture, healthcare, and food technology sectors. The fund provides investors with access to a diversified portfolio of startups, managed investment oversight, and participation rights in follow-on funding rounds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

iSelect Fund is an evergreen venture capital fund that provides accredited investors, family offices, wealth managers, and institutional investors access to vetted early-stage investment opportunities in food, agriculture, healthcare, and resource efficiency sectors. The fund conducts up to 120 hours of due diligence per portfolio company, manages investments on behalf of investors, and offers co-investment opportunities alongside top-tier venture capital firms. Securities are offered through North Capital Private Securities, a registered broker-dealer.

Product overview

iSelect Fund is a venture capital firm structured as an evergreen fund that offers investors ongoing access to investment opportunities in the food, health, and agriculture sectors. Rather than a unified software platform, the fund provides a network model connecting entrepreneurs, investors, early adopter customers, and industry experts. Investors access the fund's portfolio companies, diligence process, and industry expertise through the fund's investor portal and network services. The fund's primary offering is its investment platform, which includes vetted portfolio companies in agriculture, food tech, and healthcare verticals.

Differentiator

Problem solved

Functional benefit

Products and services

• iSelect Fund
• Co-Investment Program for Family Offices

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• The Nature ConservancycoreStrategic or Co-development PartneriSelect announced an investment collaboration with The Nature Conservancy focused on accelerating progress against ambitious soil health goals. The Nature Conservancy is a leading global conservation organization working on soil health and sustainable agriculture.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• S2G Investments: S2G is a multi-stage venture fund investing across food, agriculture, and ocean. Direct competitor to iSelect with a similar food/health thesis, larger AUM, and an existing co-investment relationship with iSelect (joint participant in Miraterra's 2026 round).
• Anterra Capital: Anterra is a venture capital firm investing globally in food, agriculture, and animal health. Direct peer to iSelect — both target the food/agtech convergence, and Anterra is an existing co-investor alongside iSelect in portfolio companies.
• Cultivian Sandbox Ventures: Cultivian Sandbox invests in early-stage food and agriculture technology companies. Direct peer to iSelect with a comparable sector mandate and an established co-investor relationship across iSelect's portfolio.
• AgFunder: AgFunder is a venture capital and media platform investing in agrifood technology. Direct competitor with overlapping investment themes (agtech, foodtech) and complementary media reach; both target the food/ag convergence.
• Pontifax AgTech: Pontifax AgTech (now part of Pontifax Global Food and Agriculture Technology Fund) invests in food and agtech. Closely comparable to iSelect on stage (early/growth) and thesis (food/agriculture technology convergence).
• Fall Line Capital: Fall Line Capital is an early-stage venture firm focused on agricultural technology. Direct peer to iSelect in agtech investing with comparable portfolio stage and sector focus.
• Breakthrough Energy Ventures: Breakthrough Energy Ventures (Bill Gates–backed) invests in companies tackling climate change, with significant overlap in agriculture, food, and health technologies. Comparable to iSelect on early-stage climate-adjacent food/ag investing.

Broad incumbents

• ADM Ventures: ADM Ventures is the corporate venture arm of Archer Daniels Midland, one of the world's largest food/ag companies. Larger incumbent operating broadly in iSelect's sector and an existing co-investor in iSelect's portfolio companies (e.g., Miraterra round).
• Khosla Ventures: Khosla Ventures is a major US venture firm with significant early-stage exposure to food, agriculture, and health technology. Larger incumbent with broader portfolio but thematic overlap with iSelect's investment areas.
• Leaps by Bayer: Leaps by Bayer is the corporate venture arm of Bayer focused on life sciences, agriculture, and health. Strategic incumbent that competes for food/ag/health deals and brings deep corporate balance sheet capacity versus iSelect's evergreen structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/iselectfund
• YouTubeyoutube.com/channel/UCO8lXo5DYw2GJh6LR68L_OA
• Facebookfacebook.com/iselectfund
• LinkedInlinkedin.com/company/iselect-fund

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments85 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iSelect Fund